News

Transform Your Breakthrough Ideas Into Successful Businesses

Are you ready to take your innovation to the next level? The Venture Challenge is a proven 10-week program designed to turn cutting-edge research or initial ideas into solid business cases in the Life Sciences sector.
timelines

Venture challenge Fall 2024 on its way

Last week the LifeSciences@Work Venture Challenge Winter 2025 kicked-off with an inspiring first 3-day workshop at
VC24 Winter

RIBOPRO Secures Series A Funding to Accelerate mRNA-Based technologies

RIBOPRO, a leading technology and service provider, specializing in the development and production of mRNA and lipid nanoparticles, today proudly announced the successful closing of a Series A funding round.
RIBOPRO Secures Series A Funding to Accelerate mRNA-Based technologies

These are the Venture Challenge Fall 2024 teams!

  Six teams have started the Venture Challenge Fall 2024! Between These starting life sciences entrepreneurs will learn everything about building and pitching a business plan.
Sfeer impressie

iProtics secures significant investment of €350,000 from UNIIQ!

We are thrilled to announce that iProtics has secured its first investment, receiving €350,000 from UNIIQ - Finance for the Future the Zuid-Holland innovation fund.
iPtrotics has secured its first investment!

Venture Challenge alumnus Predica is proud to announce its first product, the “HPV profiler”

Predica Diagnostics B.V. is active in the field of diagnostics, prognostics and prediction of treatment response in oncology. in 2018 Predica Diagnostic participated in the Venture Challenge spring edition. 
poster Predica Diagnostics

The LifeSciences@Work Venture Challenge Winner announcement at the DLSC

During the 20th edition of the foremost life sciences business networking event, the winner of the Venture Challenge Fall 2024 will be announced. Curious about the teams of this fall edition?
Winners venture challenge 2024

XS Innovations raises seed investment of EUR 1.1 m to accelerate development of vascular access device “the Dynamic AVF”

• Investment will accelerate development of a state-of-the-art vascular access device known as Dynamic AVF, to improve treatment for end-stage kidney disease patients
XS Innovations raises seed investment of EUR 1.1 m to accelerate development of vascular access device “the Dynamic AVF”

Spatium Medical B.V. raises 5 million to bring smart insufflation technology to operating rooms in europe and the United States

Venture Challenge alumnus of the spring edition 2023, Spatium Medical B.V., has successfully closed a €5 million funding round. This round includes new investors InnovationQuarter and DEMCON INVESTMENTS Fund, as well as support from existing investors: Van
Team Spatium medicals

Applications for the Termeer Fellowship Class of 2025 will open from September 30th!

Are you an early-stage CEO of an early or non-profit biotech/life sciences organisation committed to developing potentially life-changing treatments for patients?
Applications for the Termeer Fellowship Class of 2025 will open from September 30th!